CbdMD Historical Financial Ratios

YCBD Stock  USD 0.66  0.01  1.49%   
CbdMD is presently reporting on over 98 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 0.0942, Dividend Yield of 1.66, PTB Ratio of 0.25 or Days Sales Outstanding of 20.08 will help investors to properly organize and evaluate cbdMD Inc financial condition quickly.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About CbdMD Financial Ratios Analysis

cbdMD IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate CbdMD investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on CbdMD financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across CbdMD history.

CbdMD Financial Ratios Chart

At present, CbdMD's Payables Turnover is projected to slightly decrease based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.52, whereas PTB Ratio is forecasted to decline to 0.25.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing cbdMD Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on CbdMD sales, a figure that is much harder to manipulate than other cbdMD Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is cbdMD Inc dividend as a percentage of CbdMD stock price. cbdMD Inc dividend yield is a measure of CbdMD stock productivity, which can be interpreted as interest rate earned on an CbdMD investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.
Most ratios from CbdMD's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into cbdMD Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
At present, CbdMD's Payables Turnover is projected to slightly decrease based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.52, whereas PTB Ratio is forecasted to decline to 0.25.
 2021 2022 2023 2024 (projected)
Dividend Yield0.31.761.591.66
Price To Sales Ratio0.380.08620.09920.0942

CbdMD fundamentals Correlations

-0.660.910.17-0.380.710.23-0.76-0.79-0.630.911.0-0.74-0.52-0.06-0.150.320.6-0.8-0.7-0.28-0.66-0.570.76-0.51-0.67
-0.66-0.47-0.25-0.35-0.980.080.760.240.66-0.47-0.630.76-0.22-0.150.3-0.01-0.230.450.68-0.30.720.85-0.90.010.7
0.91-0.47-0.15-0.560.510.34-0.68-0.73-0.641.00.93-0.66-0.74-0.23-0.20.420.83-0.66-0.76-0.51-0.33-0.380.58-0.45-0.34
0.17-0.25-0.150.270.28-0.19-0.28-0.40.03-0.150.14-0.280.330.830.19-0.6-0.29-0.440.090.63-0.47-0.180.34-0.27-0.48
-0.38-0.35-0.560.270.34-0.38-0.080.66-0.15-0.56-0.41-0.110.790.38-0.13-0.4-0.60.26-0.030.84-0.16-0.50.160.7-0.11
0.71-0.980.510.280.34-0.07-0.77-0.28-0.680.510.69-0.770.130.15-0.230.040.21-0.5-0.70.3-0.79-0.90.910.01-0.76
0.230.080.34-0.19-0.38-0.07-0.08-0.26-0.10.340.24-0.07-0.42-0.180.010.20.35-0.15-0.16-0.350.080.09-0.01-0.20.07
-0.760.76-0.68-0.28-0.08-0.77-0.080.470.91-0.68-0.751.00.18-0.20.56-0.12-0.40.80.85-0.090.420.68-0.840.260.42
-0.790.24-0.73-0.40.66-0.28-0.260.470.2-0.73-0.80.440.58-0.19-0.12-0.02-0.590.760.320.310.410.05-0.430.780.45
-0.630.66-0.640.03-0.15-0.68-0.10.910.2-0.64-0.620.920.240.030.61-0.28-0.380.630.880.020.260.72-0.740.040.24
0.91-0.471.0-0.15-0.560.510.34-0.68-0.73-0.640.93-0.66-0.74-0.23-0.20.420.83-0.66-0.76-0.51-0.33-0.380.58-0.45-0.34
1.0-0.630.930.14-0.410.690.24-0.75-0.8-0.620.93-0.73-0.55-0.09-0.150.340.62-0.79-0.69-0.33-0.64-0.540.74-0.53-0.65
-0.740.76-0.66-0.28-0.11-0.77-0.071.00.440.92-0.66-0.730.16-0.210.57-0.11-0.380.780.86-0.110.410.69-0.840.220.41
-0.52-0.22-0.740.330.790.13-0.420.180.580.24-0.74-0.550.160.32-0.12-0.42-0.70.370.380.69-0.1-0.10.030.36-0.08
-0.06-0.15-0.230.830.380.15-0.18-0.2-0.190.03-0.23-0.09-0.210.320.28-0.87-0.09-0.15-0.040.79-0.1-0.070.170.08-0.09
-0.150.3-0.20.19-0.13-0.230.010.56-0.120.61-0.2-0.150.57-0.120.28-0.460.030.360.40.16-0.140.19-0.30.15-0.13
0.32-0.010.42-0.6-0.40.040.2-0.12-0.02-0.280.420.34-0.11-0.42-0.87-0.460.09-0.14-0.16-0.76-0.06-0.090.06-0.27-0.09
0.6-0.230.83-0.29-0.60.210.35-0.4-0.59-0.380.830.62-0.38-0.7-0.090.030.09-0.3-0.64-0.440.07-0.040.28-0.260.07
-0.80.45-0.66-0.440.26-0.5-0.150.80.760.63-0.66-0.790.780.37-0.150.36-0.14-0.30.530.140.490.42-0.660.630.51
-0.70.68-0.760.09-0.03-0.7-0.160.850.320.88-0.76-0.690.860.38-0.040.4-0.16-0.640.53-0.010.250.68-0.63-0.080.22
-0.28-0.3-0.510.630.840.3-0.35-0.090.310.02-0.51-0.33-0.110.690.790.16-0.76-0.440.14-0.01-0.2-0.340.130.54-0.16
-0.660.72-0.33-0.47-0.16-0.790.080.420.410.26-0.33-0.640.41-0.1-0.1-0.14-0.060.070.490.25-0.20.73-0.70.211.0
-0.570.85-0.38-0.18-0.5-0.90.090.680.050.72-0.38-0.540.69-0.1-0.070.19-0.09-0.040.420.68-0.340.73-0.76-0.260.69
0.76-0.90.580.340.160.91-0.01-0.84-0.43-0.740.580.74-0.840.030.17-0.30.060.28-0.66-0.630.13-0.7-0.76-0.29-0.7
-0.510.01-0.45-0.270.70.01-0.20.260.780.04-0.45-0.530.220.360.080.15-0.27-0.260.63-0.080.540.21-0.26-0.290.27
-0.670.7-0.34-0.48-0.11-0.760.070.420.450.24-0.34-0.650.41-0.08-0.09-0.13-0.090.070.510.22-0.161.00.69-0.70.27
Click cells to compare fundamentals

CbdMD Account Relationship Matchups

CbdMD fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio2.112.570.380.08620.09920.0942
Days Sales Outstanding11.849.2314.9418.3821.1320.08
Book Value Per Share80.7284.4823.674.474.023.82
Invested Capital0.110.05880.150.410.470.45
Operating Cash Flow Per Share(10.87)(11.54)(11.27)(2.13)(1.91)(2.01)
Stock Based Compensation To Revenue0.04870.06580.02620.01420.01630.0155
Capex To Depreciation(1.83)(1.04)(0.23)(0.1)(0.0915)(0.096)
Ev To Sales1.962.110.330.160.190.18
Free Cash Flow Per Share(12.22)(13.46)(11.79)(2.27)(2.05)(2.15)
Roic(0.22)(0.17)1.04(2.82)(2.54)(2.41)
Inventory Turnover3.372.893.072.262.62.47
Net Income Per Share12.85(19.16)(55.8)(11.34)(10.21)(10.72)
Days Of Inventory On Hand108.3126.46118.88161.19145.07101.7
Payables Turnover5.444.876.424.815.545.62
Capex To Revenue(0.0315)(0.0527)(0.0195)(0.0123)(0.0111)(0.0116)
Cash Per Share15.422.485.810.891.020.97
Pocfratio(8.28)(8.11)(0.9)(0.48)(0.44)(0.46)
Capex To Operating Cash Flow0.120.170.0460.06920.06220.0602
Pfcf Ratio(7.37)(6.95)(0.86)(0.45)(0.41)(0.43)
Days Payables Outstanding67.0675.0156.8975.8187.1987.04
Income Quality(0.85)0.60.210.190.170.18
Roe0.16(0.23)(2.36)(2.54)(2.29)(2.4)
Ev To Operating Cash Flow(7.7)(6.66)(0.77)(0.92)(0.83)(0.87)
Pe Ratio7.01(4.88)(0.18)(0.0908)(0.0817)(0.0858)
Return On Tangible Assets0.36(0.52)(3.23)(1.77)(2.03)(2.13)
Ev To Free Cash Flow(6.85)(5.72)(0.74)(0.86)(0.78)(0.82)
Earnings Yield0.14(0.2)(5.51)(11.01)(12.66)(12.03)
Intangibles To Total Assets0.690.640.440.20.180.17
Net Debt To E B I T D A0.131.6(0.0477)0.250.230.24
Current Ratio3.085.283.031.731.563.09

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in CbdMD Stock

When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CbdMD. If investors know CbdMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CbdMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.92)
Revenue Per Share
7.623
Quarterly Revenue Growth
(0.30)
Return On Assets
(0.19)
Return On Equity
(1.50)
The market value of cbdMD Inc is measured differently than its book value, which is the value of CbdMD that is recorded on the company's balance sheet. Investors also form their own opinion of CbdMD's value that differs from its market value or its book value, called intrinsic value, which is CbdMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CbdMD's market value can be influenced by many factors that don't directly affect CbdMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.